{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:10:29Z","timestamp":1793725829847,"version":"4.6.1"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Osteoporosis is a common complication of many types of chronic liver diseases (CLDs), such as cholestatic liver disease, viral hepatitis, and alcoholic liver disease. Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent metabolic liver disease, affecting almost one third of adults around the world, and is emerging as the dominant cause of CLDs. Liver serves as a hub for nutrient and energy metabolism in the body, and its crosstalk with other tissues, such as adipose tissue, heart, and brain, has been well recognized. However, much less is known about the crosstalk that occurs between the liver and bone. Moreover, the mechanisms by which CLDs increase the risk for osteoporosis remain unclear. This review summarizes the latest research on the liver\u2013bone axis and discusses the relationship between NAFLD and osteoporosis. We cover key signaling molecules secreted by liver, such as insulin-like growth factor-1 (IGF-1), fibroblast growth factor 21 (FGF21), insulin-like growth factor binding protein 1 (IGFBP1), fetuin-A, tumor necrosis factor-alpha (TNF-\u03b1), and osteopontin (OPN), and their relevance to the homeostasis of bone metabolism. Finally, we consider the disordered liver metabolism that occurs in patients with NAFLD and how this disrupts signaling to the bone, thereby perturbing the balance between osteoclasts and osteoblasts and leading to osteoporosis or hepatic osteodystrophy (HOD).<\/jats:p>","DOI":"10.3389\/fendo.2023.1161402","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T05:13:38Z","timestamp":1678425218000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Liver-bone crosstalk in non-alcoholic fatty liver disease: Clinical implications and underlying pathophysiology"],"prefix":"10.3389","volume":"14","author":[{"given":"Jiahui","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30702","article-title":"Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: A systematic review and meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: A review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62349-5","article-title":"Osteoporosis: now and the future","volume":"377","author":"Rachner","year":"2011","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"116353","DOI":"10.1016\/j.bone.2022.116353","article-title":"RANKL biology","volume":"159","author":"Takegahara","year":"2022","journal-title":"Bone"},{"key":"B6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.bone.2016.10.009","article-title":"Transcriptional control of sost in bone","volume":"96","author":"Sebastian","year":"2017","journal-title":"Bone"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.7498","article-title":"Screening for osteoporosis to prevent fractures: US preventive services task force recommendation statement","volume":"319","author":"Force","year":"2018","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.21995","article-title":"Treatment of osteoporosis","volume":"319","author":"Cotts","year":"2018","journal-title":"JAMA"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.21106","article-title":"Prevalence of osteoporosis and fracture in China: The China osteoporosis prevalence study","volume":"4","author":"Wang","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12873","article-title":"Treating osteoporosis to prevent fractures: Current concepts and future developments","volume":"285","author":"Lorentzon","year":"2019","journal-title":"J Intern Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/endrev\/bnab028","article-title":"Secondary osteoporosis","volume":"43","author":"Ebeling","year":"2022","journal-title":"Endocr Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2009.166","article-title":"Current understanding of osteoporosis associated with liver disease","volume":"6","author":"Nakchbandi","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.080313","article-title":"Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation","volume":"23","author":"Kawelke","year":"2008","journal-title":"J Bone Miner Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.3390\/ijms21176120","article-title":"Anti-c-fms antibody prevents osteoclast formation and bone resorption in Co-culture of osteoblasts and osteoclast precursors in vitro and in ovariectomized mice","volume":"21","author":"Nara","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.3390\/ijms18102054","article-title":"Blocking of the ubiquitin-proteasome system prevents inflammation-induced bone loss by accelerating m-CSF receptor c-fms degradation in osteoclast differentiation","volume":"18","author":"Lee","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/joim.13497","article-title":"Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort study","volume":"292","author":"Wester","year":"2022","journal-title":"J Intern Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10254-y","article-title":"Hepatic fibrosis is associated with an increased rate of decline in bone mineral density in men with nonalcoholic fatty liver disease","volume":"15","author":"Yoon","year":"2021","journal-title":"Hepatol Int"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2018.10.001","article-title":"Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes","volume":"45","author":"Mantovani","year":"2019","journal-title":"Diabetes Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-022-06459-y","article-title":"Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"33","author":"Pan","year":"2022","journal-title":"Osteoporos Int"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.599339","article-title":"Association between 10-year fracture probability and nonalcoholic fatty liver disease with or without sarcopenia in Korean men: A nationwide population-based cross-sectional study","volume":"12","author":"Lee","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/apt.15087","article-title":"Systematic review with meta-analysis: Non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density","volume":"49","author":"Mantovani","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.cmet.2022.02.006","article-title":"Defects in a liver-bone axis contribute to hepatic osteodystrophy disease progression","volume":"34","author":"Lu","year":"2022","journal-title":"Cell Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.02.007","article-title":"Reverse cholesterol transport and hepatic osteodystrophy","volume":"34","author":"Zaidi","year":"2022","journal-title":"Cell Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1210\/er.2009-0010","article-title":"The role of liver-derived insulin-like growth factor-I","volume":"30","author":"Ohlsson","year":"2009","journal-title":"Endocr Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0215463","article-title":"Circulating levels of IGF-1 directly regulate bone growth and density","volume":"110","author":"Yakar","year":"2002","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2015.06.003","article-title":"Insulin-like growth factor binding-protein-3 (IGFBP-3)","volume":"29","author":"Ranke","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80211-0","article-title":"Osteopenia in rats with liver cirrhosis: Beneficial effects of IGF-I treatment","volume":"28","author":"Cemborain","year":"1998","journal-title":"J Hepatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00204-013-1191-5","article-title":"Chronic CCl4 intoxication causes liver and bone damage similar to the human pathology of hepatic osteodystrophy: A mouse model to analyse the liver-bone axis","volume":"88","author":"Nussler","year":"2014","journal-title":"Arch Toxicol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1006\/dbio.2000.9975","article-title":"Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth","volume":"229","author":"Lupu","year":"2001","journal-title":"Dev Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1096\/fj.08-118976","article-title":"Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism","volume":"23","author":"Yakar","year":"2009","journal-title":"FASEB J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-0608","article-title":"Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion","volume":"148","author":"Govoni","year":"2007","journal-title":"Endocrinology"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1320313","article-title":"Insulin-like growth factors I and II in healthy women with and without established osteoporosis","volume":"132","author":"Ravn","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.7.4971","article-title":"Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-I","volume":"83","author":"Kurland","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/apa.13685","article-title":"Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents","volume":"106","author":"Liang","year":"2017","journal-title":"Acta Paediatr"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1038\/ctg.2016.72","article-title":"The association between IGF-1 levels and the histologic severity of nonalcoholic fatty liver disease","volume":"8","author":"Dichtel","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-01982-1","article-title":"Insulin-like growth factor-1 and non-alcoholic fatty liver disease: A systemic review and meta-analysis","volume":"65","author":"Yao","year":"2019","journal-title":"Endocrine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/1479-5876-11-271","article-title":"IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand","volume":"11","author":"Guerra-Menendez","year":"2013","journal-title":"J Transl Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2019.01.017","article-title":"Cartilage-targeted IGF-1 treatment to promote longitudinal bone growth","volume":"27","author":"Lui","year":"2019","journal-title":"Mol Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S303057","article-title":"Efficacy and safety of teprotumumab in thyroid eye disease","volume":"17","author":"Teo","year":"2021","journal-title":"Ther Clin Risk Manag"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67353","article-title":"Interplay between FGF21 and insulin action in the liver regulates metabolism","volume":"124","author":"Emanuelli","year":"2014","journal-title":"J Clin Invest"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.04.005","article-title":"Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice","volume":"17","author":"Lin","year":"2013","journal-title":"Cell Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.02.001","article-title":"A long-acting FGF21 molecule, PF-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects","volume":"23","author":"Talukdar","year":"2016","journal-title":"Cell Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1210\/er.2017-00016","article-title":"Fibroblast growth factor 21-metabolic role in mice and men","volume":"38","author":"Staiger","year":"2017","journal-title":"Endocr Rev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.07.003","article-title":"Fibroblast growth factor 21 as a biomarker for NAFLD: Integrating pathobiology into clinical practice","volume":"53","author":"Morris-Stiff","year":"2010","journal-title":"J Hepatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2010.02338.x","article-title":"Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease","volume":"40","author":"Yilmaz","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1200797109","article-title":"Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma","volume":"109","author":"Wei","year":"2012","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.09.010","article-title":"A liver-bone endocrine relay by IGFBP1 promotes osteoclastogenesis and mediates FGF21-induced bone resorption","volume":"22","author":"Wang","year":"2015","journal-title":"Cell Metab"},{"key":"B49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tips.2019.12.005","article-title":"Targeting FGF21 for the treatment of nonalcoholic steatohepatitis","volume":"41","author":"Zarei","year":"2020","journal-title":"Trends Pharmacol Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2015.00147","article-title":"Research perspectives on the regulation and physiological functions of FGF21 and its association with NAFLD","volume":"6","author":"Inagaki","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and reverse cholesterol transport","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.540427","article-title":"Compromised LCAT function is associated with increased atherosclerosis","volume":"112","author":"Hovingh","year":"2005","journal-title":"Circulation"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2012.11.003","article-title":"Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet","volume":"21","author":"Triantaphyllidou","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"key":"B54","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1530\/JOE-16-0657","article-title":"High-density lipoprotein (HDL) metabolism and bone mass","volume":"233","author":"Papachristou","year":"2017","journal-title":"J Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"300060521999555","DOI":"10.1177\/0300060521999555","article-title":"Association of dyslipidaemia with osteoporosis in postmenopausal women","volume":"49","author":"Zhang","year":"2021","journal-title":"J Int Med Res"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2021.03.001","article-title":"Positive association of high-density lipoprotein cholesterol with lumbar and femoral neck bone mineral density in postmenopausal women","volume":"147","author":"Zolfaroli","year":"2021","journal-title":"Maturitas"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00538-z","article-title":"High-density lipoproteins, reverse cholesterol transport and atherogenesis","volume":"18","author":"Pownall","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-009-0150-y","article-title":"Proteomic analysis of osteoclast lipid rafts: The role of the integrity of lipid rafts on V-ATPase activity in osteoclasts","volume":"28","author":"Ryu","year":"2010","journal-title":"J Bone Miner Metab"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmy081","article-title":"HDL impairs osteoclastogenesis and induces osteoclast apoptosis via upregulation of ABCG1 expression","volume":"50","author":"Huang","year":"2018","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"112677","DOI":"10.1016\/j.biopha.2022.112677","article-title":"LCAT- targeted therapies: Progress, failures and future","volume":"147","author":"Yang","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M600403-JLR200","article-title":"Role of LCAT in HDL remodeling: Investigation of LCAT deficiency states","volume":"48","author":"Asztalos","year":"2007","journal-title":"J Lipid Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nri2460","article-title":"Regulation of T-helper-cell lineage development by osteopontin: The inside story","volume":"9","author":"Cantor","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.3390\/nu12082206","article-title":"Early-life supplementation of bovine milk osteopontin supports neurodevelopment and influences exploratory behavior","volume":"12","author":"Joung","year":"2020","journal-title":"Nutrients"},{"key":"B64","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.3390\/nu13082670","article-title":"Osteopontin levels in human milk are related to maternal nutrition and infant health and growth","volume":"13","author":"Aksan","year":"2021","journal-title":"Nutrients"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2008.08.001","article-title":"Osteopontin: Role in immune regulation and stress responses","volume":"19","author":"Wang","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.048298","article-title":"Osteopontin\/Eta-1 upregulated in crohn's disease regulates the Th1 immune response","volume":"54","author":"Sato","year":"2005","journal-title":"Gut"},{"key":"B67","doi-asserted-by":"publisher","first-page":"eaat0344","DOI":"10.1126\/scitranslmed.aat0344","article-title":"Hepatocyte notch activation induces liver fibrosis in nonalcoholic steatohepatitis","volume":"10","author":"Zhu","year":"2018","journal-title":"Sci Transl Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31582","article-title":"Osteopontin takes center stage in chronic liver disease","volume":"73","author":"Song","year":"2021","journal-title":"Hepatology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.dld.2012.08.017","article-title":"Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease","volume":"45","author":"Yilmaz","year":"2013","journal-title":"Dig Liver Dis"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2019.1699822","article-title":"Osteopontin acts as a negative regulator of autophagy accelerating lipid accumulation during the development of nonalcoholic fatty liver disease","volume":"48","author":"Tang","year":"2020","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.07.030","article-title":"Targeting NFATc4 attenuates non-alcoholic steatohepatitis in mice","volume":"73","author":"Du","year":"2020","journal-title":"J Hepatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.16445","article-title":"Role of osteopontin in liver diseases","volume":"12","author":"Wen","year":"2016","journal-title":"Int J Biol Sci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.immuni.2020.08.004","article-title":"Osteopontin expression identifies a subset of recruited macrophages distinct from kupffer cells in the fatty liver","volume":"53","author":"Remmerie","year":"2020","journal-title":"Immunity"},{"key":"B74","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41467-021-27683-w","article-title":"Macrophages in epididymal adipose tissue secrete osteopontin to regulate bone homeostasis","volume":"13","author":"Dai","year":"2022","journal-title":"Nat Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.14.8156","article-title":"Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption","volume":"96","author":"Yoshitake","year":"1999","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M010938200","article-title":"Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin","volume":"276","author":"Ihara","year":"2001","journal-title":"J Biol Chem"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.919159","article-title":"Osteopontin in bone metabolism and bone diseases","volume":"26","author":"Si","year":"2020","journal-title":"Med Sci Monit"},{"key":"B78","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200316069","article-title":"Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis","volume":"111","author":"Ritchlin","year":"2003","journal-title":"J Clin Invest"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11176","article-title":"TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand","volume":"106","author":"Lam","year":"2000","journal-title":"J Clin Invest"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3858\/emm.2010.42.6.045","article-title":"Msx2 mediates the inhibitory action of TNF-alpha on osteoblast differentiation","volume":"42","author":"Lee","year":"2010","journal-title":"Exp Mol Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/cells11010132","article-title":"Regulation of TNF-induced osteoclast differentiation","volume":"11","author":"Yao","year":"2021","journal-title":"Cells"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11066","article-title":"Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha","volume":"106","author":"Cenci","year":"2000","journal-title":"J Clin Invest"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111566","article-title":"TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J","volume":"209","author":"Zhao","year":"2012","journal-title":"J Exp Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.110.234260","article-title":"Fetuin-a regulation of calcified matrix metabolism","volume":"108","author":"Jahnen-Dechent","year":"2011","journal-title":"Circ Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.8.2450","article-title":"Improved insulin sensitivity and resistance to weight gain in mice null for the ahsg gene","volume":"51","author":"Mathews","year":"2002","journal-title":"Diabetes"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.29.04.06.dc05-1938","article-title":"Alpha2-Heremans-Schmid glycoprotein\/fetuin-a is associated with insulin resistance and fat accumulation in the liver in humans","volume":"29","author":"Stefan","year":"2006","journal-title":"Diabetes Care"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2010.010169","article-title":"Serum fetuin A\/alpha2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: Relation with liver fibrosis","volume":"47","author":"Yilmaz","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3906\/sag-1308-28","article-title":"Serum fetuin-a levels in postmenopausal women with osteoporosis","volume":"44","author":"Ozkan","year":"2014","journal-title":"Turk J Med Sci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-012-9690-6","article-title":"The role of fetuin-a in physiological and pathological mineralization","volume":"93","author":"Brylka","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.2012.01561.x","article-title":"Role of fetuin-a in atherosclerosis associated with diabetic patients","volume":"64","author":"Singh","year":"2012","journal-title":"J Pharm Pharmacol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.56","article-title":"Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance","volume":"13","author":"Meex","year":"2017","journal-title":"Nat Rev Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1161402\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T05:13:42Z","timestamp":1678425222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1161402\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":93,"alternative-id":["10.3389\/fendo.2023.1161402"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1161402","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"article-number":"1161402"}}